Lymphoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

24Recruiting trials

Regulatory Watchboard

10 events

Jan 2026Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

The First Affiliated Hospital of Soochow University — PHASE2

TrialRECRUITING

Oct 2025Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Sintilimab for Primary Central Nervous System Lymphoma

Zhengzhou University — NA

TrialNOT YET RECRUITING

Oct 2025A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

Ono Pharmaceutical Co. Ltd — PHASE1

TrialRECRUITING

Sep 2025A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）

Ruijin Hospital — NA

TrialRECRUITING

Aug 2025A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

The Lymphoma Academic Research Organisation — PHASE1, PHASE2

TrialRECRUITING

Jul 2025WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

Mayo Clinic — NA

TrialRECRUITING

Mar 2025Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies

GC Cell Corporation — PHASE1

TrialRECRUITING

Aug 2024PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Institute of Hematology & Blood Diseases Hospital, China — PHASE2

TrialRECRUITING

Jun 2024DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

UNC Lineberger Comprehensive Cancer Center — NA

TrialRECRUITING

Mar 2024Effects of Exercise Training in Survivors of Lymphoma

Norwegian School of Sport Sciences — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Elitek

Sanofi-Synthelabo Research

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Elitek

(rasburicase)Orphan drugstandard

Sanofi-Synthelabo Research

12.1 Mechanism of Action In humans, uric acid is the final step in the catabolic pathway of purines. Rasburicase catalyzes enzymatic oxidation of poor...

View full treatment details on disease page →

Clinical Trial Landscape

24 active trials

7Phase 2

4Phase 1

7N/A

5Unknown

1PHASE1, PHASE2

24Total recruiting

Search clinical trials for Lymphoma →

Recent News & Research

No recent news articles indexed yet for Lymphoma.
Search PubMed for Lymphoma →

Browse all Lymphoma news →

Specialist Network

Top 6 by expertise

Won Seog Kim, Dr

Samsung Medical Center

Score 351 trial

Shuhua Yi, Dr

Institute of Hematology & Blood Diseases Hospital, Chinese

Score 161 trial

Liang Wang, M.D.

Beijing Tongren Hospital

Score 124 trials

Christian Gisselbrecht

Lymphoma Study Association

Score 91 trial6 pubs

Steven Horwitz, MD

Memorial Sloan Kettering Cancer Center

Score 94 trials

Karenza Alexis, MD, MD

Affimed Inc.

📍 BRONX, NY

View all Lymphoma specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles